Parameter
| Biomarker | CXCL-12 | Full name | C-X-C Motif Chemokine Ligand 12 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis, monitoring | ||
| Disease | Acute Myeloid Leukemia (AML) | Disease Subtypes | / | ||
| Organ | Blood, bone marrow | Test Sample / Technology Platform | Bone marrow plasma (ELISA) | ||
| Pathobiological Mechanisms | Down-regulated during diagnosis, up-regulated after complete remission and relapse, reflecting changes in the bone marrow microenvironment. | ||||
| Clinical Availability Status | Research validation: Inverse correlation with Activin-A expression. | ||||
| Notes and Dynamics | As an auxiliary biomarker for disease progression monitoring. | ||||